Novolog (Pharm-Up 1966) Ltd — Cyborg Score 6/10

Solid
Healthcare Services / Medical Distribution / Pharmaceutical Logistics

Strategic Profile

Novolog operates a diversified three-segment model positioning it uniquely in Israel's fragmented healthcare landscape. The company's competitive moat stems from established relationships with major pharma companies, proprietary logistics infrastructure including clinical trial management capabilities, and expanding digital health platforms serving patients and practitioners.

Cyborg Score Rationale

Novolog demonstrates stable market positioning with diversified revenue streams across logistics, health services, and digital segments. However, the company faces scale limitations in the Israeli market and moderate growth dynamics. The relatively high PE ratio (58.85) suggests limited near-term upside despite solid operational fundamentals.

Top Insights

  • Integrated supply chain model creates sticky customer relationships with multinational pharma companies seeking single-source logistics partners
  • Digital health division addresses emerging telemedicine and health information accessibility trends in Israeli healthcare
  • Clinical trials logistics (Trialog subsidiary) captures growing biotech R&D activity in Israel
  • Relatively concentrated market position in small Israeli healthcare ecosystem limits expansion opportunities domestically

Named Competitors

  • General pharmaceutical logistics — Global players entering Israeli market
  • Digital health platforms — Emerging telemedicine and health information solutions
  • Medical laboratory services — Competing diagnostic and personalized medicine services

Recent Developments

  • (Feb 2026) Stock price trading around 119-131 ILA with moderate volatility and market cap approximately 601M ILA
  • (2024) 936 full-time employees supporting operations across three business divisions
  • (Ongoing) Expansion of digital health services and telemedicine capabilities for healthcare providers

Open the full interactive Novolog (Pharm-Up 1966) Ltd report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →